Skip to Main Content
Advertisement
Close
AACR Journals
Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics
For Authors
Information for Authors
Author Services
Journal Awards
Best of: Author Profiles
About Us
AACR Journals
Advertising
Permissions & Reprints
Subscriptions
Submit
Article Collections
Journal Collections
Hot Topics
'Best Of' Collection
Editors' Picks
COVID-19
Webinars
Search Dropdown Menu
header search
search input
Search input auto suggest
Search
Advanced Search
User Tools Dropdown
Register
Sign In
Toggle Menu
Menu
About
The Journal
AACR Journals
Subscriptions
Permissions and Reprints
Articles
Online First
Issues
CCR Focus Archives
Meeting Abstracts
Collection: Clinical Trials 2022
Collection: Sarcoma
Collection: Lymphoma
Collection: Breast Cancer
Collection: Clinical Trials
Collection: Immunotherapy: Facts and Hopes
Collection: Editors' Picks
Collection: 'Best 'Of' Collection
For Authors
Information for Authors
Author Services
Best of: Author Profiles
Submit
Alerts
News
COVID-19
Webinars
Skip Nav Destination
Issues
Select Year
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Issue
1 January - Volume 23, Issue 1, Pages 1 - 323
1 January - Volume 23, Issue 1_Supplement
15 January - Volume 23, Issue 2, Pages 325 - 612
1 February - Volume 23, Issue 3, Pages 613 - 870
15 February - Volume 23, Issue 4, Pages 871 - 1119
1 March - Volume 23, Issue 5, Pages 1121 - 1361
15 March - Volume 23, Issue 6, Pages 1363 - 1620
1 April - Volume 23, Issue 7, Pages 1621 - 1876
15 April - Volume 23, Issue 8, Pages 1877 - 2127
1 May - Volume 23, Issue 9, Pages 2129 - 2373
15 May - Volume 23, Issue 10, Pages 2375 - 2605
1 June - Volume 23, Issue 11, Pages 2607 - 2918
1 June - Volume 23, Issue 11_Supplement
15 June - Volume 23, Issue 12, Pages 2919 - 3226
1 July - Volume 23, Issue 13, Pages 3227 - 3475
15 July - Volume 23, Issue 14, Pages 3477 - 3973
1 August - Volume 23, Issue 15, Pages 3975 - 4523
15 August - Volume 23, Issue 16, Pages 4525 - 4944
1 September - Volume 23, Issue 17, Pages 4945 - 5322
15 September - Volume 23, Issue 18, Pages 5323 - 5658
1 October - Volume 23, Issue 19, Pages 5659 - 5995
15 October - Volume 23, Issue 20, Pages 5997 - 6377
1 November - Volume 23, Issue 21, Pages 6379 - 6756
15 November - Volume 23, Issue 22, Pages 6757 - 7152
1 December - Volume 23, Issue 23, Pages 7153 - 7434
1 December - Volume 23, Issue 23_Supplement, Pages 3 - 78
15 December - Volume 23, Issue 24, Pages 7435 - 7672
15 December - Volume 23, Issue 24_Supplement, Pages 2 - 54
Volume 23, Issue 1_Supplement
1 January 2017
ISSN 1078-0432
EISSN 1557-3265
Close mobile search navigation
In this Issue
Keynote Address
Clinical Trials in Progress
Immunotherapy and Targeting Inflammation
Oncoproteins for Degradation
Preventing Invasion and Metastasis
Regulating Cellular Energetics
Targeting Epigenetics
Targeting Genomic Instability
Targeting Multiple Hallmarks of Cancer
Targeting Oncoproteins fo Degradation
Targeting Pathway Addiction and Resistance
Targeting Programmed Cell Death and Autophagy
Other Topics
Issue Navigation
Issue Category Search
Abstracts: AACR Precision Medicine Series: Targeting the Vulnerabilities of Cancer; May 16-19, 2016; Miami, FL
Keynote Address
Clinical Trials in Progress
Immunotherapy and Targeting Inflammation
Oncoproteins for Degradation
Preventing Invasion and Metastasis
Regulating Cellular Energetics
Targeting Epigenetics
Targeting Genomic Instability
Targeting Multiple Hallmarks of Cancer
Targeting Oncoproteins fo Degradation
Targeting Pathway Addiction and Resistance
Targeting Programmed Cell Death and Autophagy
Other Topics
All Issues
Advertisement
Email alerts
Online First Alert
eTOC Alert
Close Modal
Latest
Most Read
Most Cited
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation
Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)
FOXM1
Variant Contributes to Gefitinib Resistance via Activating Wnt/β-Catenin Signal Pathway in Patients with Non–Small Cell Lung Cancer
Extracellular vesicles may predict response to radioembolization and sorafenib treatment in advanced hepatocellular carcinoma
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
Accept
